Prevention of doxorubicin induced cardiotoxicity by catechin

Cancer Letters

Volumn 99, Issue 1, 1996, Pages 1-6

  Kozluca, Osman ^a   Olcay, Ekmel ^b   Sürücü, Selçuk ^c   Güran, Zeki ^d   Kulaksiz, Tülin ^b   Üskent, Necdcet ^e  

^a Kartal State Hospital   (Turkey)

^b Hyg and Med Research Institution   (Turkey)

^c HACETTEPE UNIVERSITY   (Turkey)

^d ANKARA ONCOLOGY HOSPITAL   (Turkey)

^e GATA HAYDARPASA TRAINING HOSPITAL   (Turkey)

Author keywords

Cardiotoxicity; Catechin; Doxorubicin

Indexed keywords

ANTHRACYCLINE ANTIBIOTIC AGENT; ANTIOXIDANT; CATECHIN; DOXORUBICIN; OXYGEN RADICAL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CARDIOTOXICITY; CONTROLLED STUDY; ELECTROCARDIOGRAM; ELECTRON MICROSCOPE; HEART MUSCLE CONTRACTILITY; HEART PROTECTION; IRON CHELATION; MALE; METABOLIC ACTIVATION; NONHUMAN; PRIORITY JOURNAL; RAT; SOLID TUMOR;

ANIMALIA;

EID: 0030034882     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3835(95)04021-8     Document Type: Article

References (28)

1. Torti, F.M., Bristow, M.R., Howes, A.E. et al. (1983) Reduced cardiotoxicity of doxorubicin and delivered on a weekly schedule. Assessment by endomyocardial biopsy. Ann. Int. Med., 99, 745-749.
2. Bonfante, V., Ferrari, L., Brambilla, C. et al. (1986) New anthracycline analogs in advanced breast cancer. Eur. J. Cancer Clin. Oncol., 22, 1379-1385.
3. Wang, Y., Madanat, F.F., Kiniball, J.C. et al. (1980) Effect of vitamin E against adriamycin induced cardiotoxicity in rabbits. Cancer Res., 40, 1022-1027.
4. Gabrecht, M., Mullerleile, U. et al. (1986) Verapamil in the prevention of adriamycin induced cardiomyopathy. Klin. Wochenschr., 64(suppl. 7), 132-134.
5. Herman, E.H., Ferrans, V.J. et al. (1986) Pretreatment with ICRF-I87 provides long lasting protection against chronic daunorubicin cardiotoxicity in rabbits. Cancer Chemother. Pharmacol., 16, 102-106.
6. Balanehru, S., Nagarajan, B. et al. (1992) Intervention of adriamycin induced free radical damage. Biochemistry. Int., 28, 735-744.
7. Yastibiro, Y., Nakazava, M., Abe, T. et al. (1986) Prevention of doxorubicin myocardial toxicity in mice by reduced glutathione. Cancer Res., 46, 2551-2556.
8. Villani, F., Galimberti, M., Zunino, F. et al. (1991) Prevention of doxorubicin induced cardiomyopathy by reduced glutathione. Cancer Chemother. Pharmacol., 28, 365-369.
9. Villani, F., Galimberti, M., Monti, E. et at. (1991) Effect of flunarizine on the delayed cardiotoxicity of doxorubicin in rats. Pharmacol. Res., 23, 193-202.
10. Bachur, NR., Gordon, SL., Gee, MV. et al. (1978) A general mechanism for microsomal activation of quinone anticancer agents to free radicals. Cancer Res., 38, 1745-1750.
11. Myers, CE., Mc Guire, W.P., Liss, R.H. et al. (1977) Adriamycin: the role of lipid peroxidation in cardiac toxicity and tumor response. Science, 197, 165-167.
12. Sankaran, R., Politi, P.M., Sinha, B.K. et al. (1988) Adriamycin induced free radical formation in perfused rat hearts: implications for cardiotoxicity. Cancer Res., 48, 4766-4769.
13. Kalyanaratnan, B., Sealy, R.C., Sinha B.K. et al. (1984) An electron spin resonance study of the reduction of peroxides by anthroacycline semiquinones. Biochim. Biophys. Acta, 799, 270-275.
14. Mimnaugh, E.G., Kenedy, K.A., Trush, M.T. et al. (1985) Adriamycin enhanced membrane lipid peroxidation in isolated rat nuclei. Cancer Res., 45, 3296-3304.
15. Myers, C.E., Muindi, J.R.F., Zweier, J. and Sinha, B.K. (1987) 5-Immunodaunomycin, an anthracycline with unique properties. J. Biol. Chem., 262, 11571-11577.
16. Dorosho, J.J. et. al. (1983) Effect of anthracyline antibiotics on oxygen radical formation in rat heart. Cancer Res., 43, 460-472.
17. Sinha, B.K. (1982) Cardiotoxicity of anthracyclines and other antitumor drugs. In: Cardiovascular Toxicology, pp. 181-197. Editor: E.W. Van Stee. Raven Press, New York.
18. Havsteen, B. (1983) Commentary: Flavonoids, a class of natural products of high pharmalogical potency. Biochem. Pharmacol., 32, 1141-1148.
19. Joseph, T., Cillard, J., Cillard, P. et al. (1986) Antioxidant activity of flavonoids and reactivity with peroxy radical. Phytochemistry, 25, 283-285.
20. Tasdemir, O., Katircioglu, S.S., Kucuksu, D.S. et al. (1993) Warmblood cardioplegia: ultrastructural and hemodynamic study. Ann. Thorac. Surg., 56, 305-311.
21. Ferrans, B.J. (1978) Overview of cardiac pathology in relation to anthracycline cardiotoxicity. Cancer Treat. Rep., 69, 955-961.
22. Cesar, G.F, Virginia, S.M., Graciela, E.F. et al. (1987) Flavonoids as antioxidants evaluated by in vitro and in situ liver chemiluminescence. 36, 717-720.
23. Antonious, M.M., Vander, K., Leendert, J. et al. (1988) Iron load increases the susceptibility of rat hearts to oxygen reperfusion damage. Protection by the antioxidant (+)-cyanidanol-3 and deferoxamine. Circulation, 78, 442-449.
24. Husain, R., Cillard, J., Cillard, P. et al. (1987) Hydroxyl radical scavenging activity of flavonoids. Photochemistry, 26, 2489-2491.
25. Morel, I., Lescoat, G., Cagrel, P. et al. (1993) Antioxidant and iron chelating activities of the flavonoids catechin, quercetin and diometin on iron loaded rat hepatocyte cultures. Biochem. Pharmacol., 5, 13-19.
26. Ratty, A.K., Das, N.P. et al. (1988) Effects of flavonoids on non-enzymatic lipid peroxidation: structure activity relationship. Biochem. Med. Metab. Biol., 39, 69-79.
27. Bors, W., Heller W., Michel, G. et al. (1990) Flavonoids as antioxidants: determination of radical scavenging efficiencies. Methods Enzymol., 186, 343-355.
28. William, F.H., Fraces, S.K., William, J.R. et al. (1986) Inhibition of mitochondrial respiration and production of toxic oxygen radicals by flavoids. A structure activity study. Biochem. Pharmacol., 35, 2345-2357.